{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:01:25Z","timestamp":1762459285114},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,25]],"date-time":"2015-04-25T00:00:00Z","timestamp":1429920000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13046-015-0157-2","type":"journal-article","created":{"date-parts":[[2015,4,24]],"date-time":"2015-04-24T01:07:21Z","timestamp":1429837641000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells"],"prefix":"10.1186","volume":"34","author":[{"given":"Caroline","family":"van Haaften","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnoud","family":"Boot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem E","family":"Corver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap DH","family":"van Eendenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baptist JMZ","family":"Trimbos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"van Wezel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,25]]},"reference":[{"key":"157_CR1","volume-title":"Atlas of Tumor Pathology, Third Series","author":"RE Scully","year":"1998","unstructured":"Scully RE, Youg RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube and broad ligament. In: Scully RE, Young RH, Clement PB, editors. Atlas of Tumor Pathology, Third Series. Washington, DC: Armed Forces Institute of Pathology; 1998."},{"key":"157_CR2","doi-asserted-by":"publisher","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","volume":"66","author":"MF Clarke","year":"2006","unstructured":"Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CHM, Jones DL, et al. Cancer stem cells-Perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006;66:9339\u201344.","journal-title":"Cancer Res"},{"key":"157_CR3","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1007\/s12032-012-0252-6","volume":"29","author":"AK Guddati","year":"2012","unstructured":"Guddati AK. Ovarian cancer stem cells: elusive targets for chemotherapy. Review article. Med Oncol. 2012;29:3400\u20138.","journal-title":"Med Oncol"},{"key":"157_CR4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrc3144","volume":"11","author":"S Vaughan","year":"2011","unstructured":"Vaughan S, Coward JI, Bast RC, Berchuk A, Berek JS, Brenton JD, et al. Rethinking Ovarian cancer: Recommendations for Improving Outcomes. Nat Rev Cancer. 2011;11:719\u201325.","journal-title":"Nat Rev Cancer"},{"key":"157_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/bjc.1994.55","volume":"69","author":"AP Jekunen","year":"1994","unstructured":"Jekunen AP, Christen RD, Shalinsky DR, Howell SB. Synergistic interaction between cisplatin and paclitaxel in human ovarian carcinoma cells in vitro. Br J Cancer. 1994;69:299\u2013306.","journal-title":"Br J Cancer"},{"key":"157_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/0959-8049(94)00440-G","volume":"1","author":"U Vanhoefer","year":"1995","unstructured":"Vanhoefer U, Harstrick A, Wilke H, Schleucher N, Walles H, Schr\u00f6der J, et al. Schedule-dependent Antagonism of Paclitaxel and Cisplatin in Human Gastric and Ovarian Carcinoma Cell lines In Vitro. Eur J Cancer. 1995;1:92\u20137.","journal-title":"Eur J Cancer"},{"key":"157_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/187152007779314044","volume":"7","author":"V Cepeda","year":"2007","unstructured":"Cepeda V, Fuertes MA, Catilla J, Alonso C, Quevedo C, Perez JM. Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem. 2007;7:3\u201318.","journal-title":"Anticancer Agents Med Chem"},{"key":"157_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1756-9966-30-29","volume":"1","author":"C Haaften Van","year":"2011","unstructured":"Van Haaften C, Duke CC, Weerheim AM, Smit NPM, van Haard PMM, Darroud F, et al. Potent cytotoxic effects of Calomeria amaranthoiddes on ovarian cancers. J Exp Clin Cancer Res. 2011;1:29.","journal-title":"J Exp Clin Cancer Res"},{"key":"157_CR9","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1248\/cpb.24.1419","volume":"24","author":"N Tanaka","year":"1976","unstructured":"Tanaka N, Yazawa T, Aoyama K, Murakami T. Chemische untersuchungen der inhaltstoffe von Xanthium canadense Mill. Chem Pharm Bull. 1976;24:1419\u201321.","journal-title":"Chem Pharm Bull"},{"key":"157_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4236\/gsc.2011.14020","volume":"1","author":"CC Duke","year":"2011","unstructured":"Duke CC, van Haaften C, Tran VH. Effici\u00ebnt isolation of an anti-cancer sesquiterpene lactone from Calomeria amaranthoides by steam distillation. Green Sustainable Chem. 2011;1:123\u20137.","journal-title":"Green Sustainable Chem"},{"key":"157_CR11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.drudis.2010.06.002","volume":"15","author":"A Ghantous","year":"2010","unstructured":"Ghantous A, Gali-Muhtasib H, Vuorela H, Saliba NA, Darwiche N. What made sesquiterpene lactones reach clinical trials? Drug Discov Today. 2010;15:668\u201378.","journal-title":"Drug Discov Today"},{"key":"157_CR12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/CAD.0b013e328356cad9","volume":"23","author":"MRO Kreuger","year":"2012","unstructured":"Kreuger MRO, Grootjans S, Biavatti MW, Vandenabeele P, D\u2019Herde K. Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide. Anticancer Drugs. 2012;23:883\u201396.","journal-title":"Anticancer Drugs"},{"key":"157_CR13","first-page":"3725","volume":"43","author":"C Haaften-Day Van","year":"1983","unstructured":"Van Haaften-Day C, Russell P, Rugg C, Wills EJ, Tattersall MHN. Flow cytometric and morphological studies of ovarian carcinoma cell lines and xenografts. Cancer Res. 1983;43:3725\u201331.","journal-title":"Cancer Res"},{"key":"157_CR14","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1158\/1535-7163.MCT-11-0693","volume":"11","author":"M Wong","year":"2012","unstructured":"Wong M, Tan N, Zha J, Peale FV, Yue P, Fairbrother WJ, et al. Navitoclax (ABT-263) reduces Bcl-XL-mediated chemoresistance in ovarian cancer models. Mol Cancer Ther. 2012;11:1026\u201335.","journal-title":"Mol Cancer Ther"},{"key":"157_CR15","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","volume":"68","author":"S Zhang","year":"2008","unstructured":"Zhang S, Balch C, Chan MW, Lai H-C, Matei D, Schilder JM, et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 2008;68:4311\u201320.","journal-title":"Cancer Res"},{"key":"157_CR16","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1200\/JCO.1999.17.7.2069","volume":"17","author":"PA Vasey","year":"1999","unstructured":"Vasey PA, Paul J, Birt A, Junor EJ, Reed NS, Symonds RP. Docepaclitaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer. J Clin Oncol. 1999;17:2069\u201380.","journal-title":"J Clin Oncol"},{"key":"157_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ygyno.2005.02.006","volume":"98","author":"JA Smith","year":"2005","unstructured":"Smith JA, Ngo H, Martin MC, Wolf JK. An evaluation of cytotoxicity of the taxane and platinum agents combination treatment in a panel of human ovarian carcinoma cell lines. Gynecol Oncol. 2005;98:141\u20135.","journal-title":"Gynecol Oncol"},{"key":"157_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1756-9966-30-87","volume":"30","author":"RS Wong","year":"2011","unstructured":"Wong RS. Apoptosis in cancer: from pathogenesis to treatment. Review article. J Exp Clin Cancer Res. 2011;30:87.","journal-title":"J Exp Clin Cancer Res"},{"key":"157_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","volume":"6","author":"AG Porter","year":"1999","unstructured":"Porter AG, Janicke RU. Emerging roles of caspase-3 in apoptosis. Review article. Cell Death Diff. 1999;6:99\u2013104.","journal-title":"Cell Death Diff"},{"key":"157_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/1568011053765976","volume":"5","author":"S Zhang","year":"2005","unstructured":"Zhang S, Won Y-K, Ong C-N, Shen H-M. Anti-cancer potential of sesquiterpene lactones: bioactivity and molecular mechanisms. Curr Med Chem Anti-Cancer Agents. 2005;5:239\u201349.","journal-title":"Curr Med Chem Anti-Cancer Agents"},{"key":"157_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1006\/gyno.1997.4637","volume":"65","author":"RK Gibb","year":"1997","unstructured":"Gibb RK, Taylor DD, Wan T, O\u2019Connor DM, Doering DL, Cercel-Taylor C. Apoptosis as a measure of chemosensitivity to cisplatin and paclitaxel therapy in ovarian cancer cell lines. Gynecol Oncol. 1997;65:13\u201322.","journal-title":"Gynecol Oncol"},{"key":"157_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s11010-011-1178-6","volume":"363","author":"L Wang","year":"2012","unstructured":"Wang L, Mezencev R, Bowen NJ, Matyunina LV, McDonald JF. Isolation and characterization of stem-like cells from a human ovarian cancer cell line. Mol Cell Biochem. 2012;363:257\u201368.","journal-title":"Mol Cell Biochem"},{"key":"157_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1475-2867-13-77","volume":"13","author":"X Wang","year":"2013","unstructured":"Wang X, Pan L, Mao N, Sun L, Qin X, Yin J. Cell-cycle synchronization reverses Paclitaxel resistance of human ovarian cancer cell lines. Cancer Cell Internat. 2013;13:77\u201385.","journal-title":"Cancer Cell Internat"},{"key":"157_CR24","doi-asserted-by":"publisher","first-page":"863","DOI":"10.7314\/APJCP.2015.16.3.863","volume":"16","author":"ST Rabe","year":"2015","unstructured":"Rabe ST, Emami SA, Iranshahi M, Rastin M, Tabasi N, Mahmoudi M. Anti-cancer properties of a sesquiterpene lactone-bearing fraction from Artemisia khorassanica. Asian Pac J Cancer Prev. 2015;16:863\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"key":"157_CR25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/aps.2014.143","volume":"36","author":"H Zhang","year":"2015","unstructured":"Zhang H, Kuang S, Wang Y, Sun X, Gu Y, Hu L, et al. Bigelovin inhibits STAT3 signaling by inactivating JAK2 and induces apoptosis in human cancer cells. Acta Pharmacol Sin. 2015;36:507\u201316.","journal-title":"Acta Pharmacol Sin"},{"key":"157_CR26","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.4161\/cc.7.10.5953","volume":"7","author":"J Zhou","year":"2008","unstructured":"Zhou J, Zhang Y. Cancer stem cells. Models, mechanisms and implications for improved treatment. Cell Cycle. 2008;7:1360\u201370.","journal-title":"Cell Cycle"},{"key":"157_CR27","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/pros.20931","volume":"69","author":"BT Kawasaki","year":"2009","unstructured":"Kawasaki BT, Hurt EM, Kalathur M, Duhagon MA, Milner JA, Kim YS, et al. Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approach. Prostate. 2009;69:827\u201337.","journal-title":"Prostate"},{"key":"157_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1756-9966-32-48","volume":"32","author":"F Tomao","year":"2013","unstructured":"Tomao F, Papa A, Rossi L, Strudel M, Vici P, Lo Russo G, et al. Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach. Review. J Exp Clin Cancer Res. 2013;32:48.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Journal of Experimental & Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-015-0157-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-015-0157-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-015-0157-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-015-0157-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T23:32:36Z","timestamp":1651793556000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-015-0157-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,25]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["157"],"URL":"https:\/\/doi.org\/10.1186\/s13046-015-0157-2","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,25]]},"assertion":[{"value":"29 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"38"}}